"The LSU Healthcare Network (LSUHN) is a group of multi-specialty physician practices. Comprised of members of the LSU Health Sciences Center faculty, LSUHN is a private, not-for-profit organization and has been serving patients in outpatient clinics since 1997. LSUHN is proud to offer over 30 specialties with numerous subspecialties to meet your healthcare needs. Utilizing a state-of-the-art electronic health records system, LSUHN is able to provide better coordination of care – from primary care to specialty care, as well as diagnostics. No matter which LSUHN location you choose, our doctors and medical staff all share one common goal: quality patient care. Visit or call our Metairie multispeciality clinic today!"

During the past decade, LSU Healthcare Network / Metairie Multi-Specialty Clinic conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 1 clinical trials were completed, i.e. on average, 3% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 1 clinical trials were completed. i.e. 5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "LSU Healthcare Network / Metairie Multi-Specialty Clinic" #1 sponsor was "National Cancer Institute (NCI)" with 13 trials, followed by "NRG Oncology" with 7 trials sponsored, "SWOG Cancer Research Network" with 6 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "LSU Healthcare Network / Metairie Multi-Specialty Clinic" #1 collaborator was "National Cancer Institute (NCI)" with 20 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "NRG Oncology" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "LSU Healthcare Network / Metairie Multi-Specialty Clinic" are "Prostate Adenocarcinoma" (5 trials), "Stage IV Renal Cell Cancer AJCC v8" (4 trials), "Metastatic Malignant Neoplasm in the Bone" (3 trials), "Sarcomatoid Renal Cell Carcinoma" (3 trials) and "Stage IVA Prostate Cancer AJCC v8" (3 trials). Many other conditions were trialed in "LSU Healthcare Network / Metairie Multi-Specialty Clinic" in a lesser frequency.

Most popular intervention types in "LSU Healthcare Network / Metairie Multi-Specialty Clinic" are "Drug" (22 trials), "Other" (20 trials), "Procedure" (14 trials), "Radiation" (13 trials) and "Biological" (10 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (11 trials), "Questionnaire Administration" (10 trials), "Radiation Therapy" (7 trials), "Bicalutamide" (5 trials) and "Biospecimen Collection" (5 trials). Other intervention names were less common.

The vast majority of trials in "LSU Healthcare Network / Metairie Multi-Specialty Clinic" are 21 trials for "All" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "LSU Healthcare Network / Metairie Multi-Specialty Clinic". undefined are not yet recruiting, 21 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in LSU Healthcare Network / Metairie Multi-Specialty Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in LSU Healthcare Network / Metairie Multi-Specialty Clinic, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".